Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Rite Aid Corporation    RAD

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets

Rite Aid March Same-Store Sales Rose 3.6%

share with twitter share with LinkedIn share with facebook
share via e-mail
0
04/05/2012 | 03:02pm CEST

Rite Aid Corp.'s (>> Rite Aid Corporation) same-store sales rose 3.6% in March, continuing a streak of monthly growth for the drugstore chain.

The No. 3 U.S. drugstore chain behind Walgreen Co. (WAG) and CVS Caremark Corp. (>> CVS Caremark Corporation) reported same-store sales growth in all but one month during 2011; March 2011 had a 0.1% drop. Last month Rite Aid reported its fourth-quarter same-store sales rose 3%, its best showing in five years.

Analysts have been expecting Rite Aid and CVS to gain market share as a result of Walgreen's exiting pharmacy benefits manager Express Scripts Holding Co.'s (ESRX) network late last year. The move was expected to result in some of Walgreen's customers going to competitors such as Rite Aid to fill prescriptions.

During March, same-store sales were up 4.6% in the front of the store.

Pharmacy same-store sales increased 3.2%, despite a negative impact of 2.4 percentage points from generic drug introductions. Same-store prescription counts grew 2.6%.

Total March drugstore sales rose 3.1% to $1.99 billion. Prescription sales accounted for 69.2% of drugstore sales.

Rite-Aid, which has about 4,659 stores, has posted losses since its 2007 acquisition of the Brooks and Eckerd chain stores that saddled it with debt just before consumers slashed spending.

The company in December reported that its fiscal third-quarter loss narrowed on higher same-store sales as the drugstore chain's wellness and loyalty and flu-immunization programs lifted pharmacy-department sales.

Shares were up 2.3% at $1.75 in recent premarket trading.

-By Tess Stynes, Dow Jones Newswires; 212-416-2481; [email protected]

Stocks mentioned in the article : Rite Aid Corporation, CVS Caremark Corporation
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on RITE AID CORPORATION
09/22 INTERRA RESOURCES : Walgreens-Rite Aid deal gets regulatory green light
09/22 LAW AND ORDER : Albion woman accused of stealing oral hygiene products from Rite..
09/21 LAW AND ORDER : Man accused of stealing cologne from Rite Aid arrested
09/20 Biz quicks
09/20 RITE AID, WALGREENS DEAL : What's happening, what does it mean, what's next?
09/20 FTC Commissioner McSweeny Comments on Walgreens/Rite Aid Transaction
09/20 INTERRA RESOURCES : FTC Acting Chairman Ohlhausen Comments on Walgreens/Rite Aid..
09/20 Walgreens, Rite Aid trim their deal; Business briefing; Homebuilding drops in..
09/20 INTERRA RESOURCES : Following Attorney General Schneiderman Investigation, Walgr..
09/20 Walgreens, Rite Aid trim purchase deal to $4.38B
More news
News from SeekingAlpha
09/23 Stocks to Watch Next Week
09/22 RITE AID'S REVISED DEAL : What Now?
09/19 WALGREENS BOOTS ALLIANCE : How The $4 Billion Rite Aid Deal Improves This Divide..
09/19 Midday Gainers / Losers
09/19 PREMARKET LOSERS AS OF 9 : 05 am
Financials ($)
Sales 2018 31 088 M
EBIT 2018 285 M
Net income 2018 -142 M
Debt 2018 6 795 M
Yield 2018 -
P/E ratio 2018 -
P/E ratio 2019
Capi. / Sales 2018 0,30x
Capi. / Sales 2019 0,08x
Capitalization 2 517 M
Chart RITE AID CORPORATION
Duration : Period :
Rite Aid Corporation Technical Analysis Chart | RAD | US7677541044 | 4-Traders
Technical analysis trends RITE AID CORPORATION
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 8
Average target price 2,45 $
Spread / Average Target 2,5%
EPS Revisions
Managers
NameTitle
John T. Standley Chairman & Chief Executive Officer
Bryan B. Everett Chief Operating Officer-Rite Aid Stores
Darren W. Karst Chief Financial & Administrative Officer, SEVP
Steve Rempel Chief Information Officer & Senior Vice President
Joseph B. Anderson Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
RITE AID CORPORATION-71.00%2 517
RAIA DROGASIL SA24.25%7 903
AIN HOLDINGS INC1.29%2 448
PALTAC CORP53.22%2 403
ORIOLA OYJ-20.42%761
PETMED EXPRESS INC53.14%728